8-KAcquisitions & DispositionsExhibits & Filings

AGILENT TECHNOLOGIES, INC. 8-K Report, Acquisition Completed (Jul 5, 2012)

Filed July 5, 2012For Securities:A

Summary

Agilent Technologies, Inc. has completed the acquisition of Dako A/S, a Danish company specializing in cancer diagnostics, for approximately $2.2 billion in cash. This strategic acquisition, finalized on June 21, 2012, is expected to enhance Agilent's presence in the life sciences and diagnostics markets, particularly in the area of cancer research and testing. The company has indicated that the financial statements for the acquired business and pro forma financial information will be filed via amendment within 71 days of this report. Investors should monitor these upcoming filings for a comprehensive understanding of Dako's financial impact on Agilent.

Key Highlights

  • 1Agilent Technologies completed the acquisition of Dako A/S on June 21, 2012.
  • 2The acquisition price was approximately $2.2 billion in cash, subject to post-closing adjustments.
  • 3Dako A/S is a Danish company focused on cancer diagnostics.
  • 4This move strengthens Agilent's position in the life sciences and diagnostics sector.
  • 5Dako A/S is now a wholly owned subsidiary of Agilent Technologies Europe B.V.
  • 6Required financial statements and pro forma information will be filed in an amendment within 71 days.

Frequently Asked Questions

This 8-K filing announces the completion of Agilent Technologies' acquisition of Dako A/S and provides details on the transaction, including the date of completion and the approximate cash enterprise value.

Dako A/S is a Danish company that specializes in cancer diagnostics. Agilent acquired Dako to expand its presence and offerings in the life sciences and diagnostics market, particularly in areas related to cancer research and patient testing.

Agilent has stated that the specific financial statements of Dako A/S and pro forma financial information reflecting the acquisition will be filed by amendment within 71 calendar days of this Form 8-K filing.

The acquisition was completed for an approximate cash enterprise value of $2.2 billion. This amount is subject to a post-closing adjustment based on working capital and net debt.